6 results match your criteria tratamiento futuros

  • Page 1 of 1

Acute portal vein thrombosis in mild cholecystitis. A consequence of coronavirus disease 2019 infection?

Cir Cir 2021 ;89(3):399-402

Department of General Surgery and Digestive System, Hospital QuirónSalud Sur, Alcorcón. Madrid, Spain.

La infección por el virus SARS-CoV-2 provoca, además de cuadros respiratorios graves, episodios trombóticos en múltiples localizaciones debido a una mala regulación de la respuesta inmune. Presentamos el caso de un paciente con colecistitis incipiente que desarrolló trombosis portal aguda sin ningún otro antecedente salvo haber pasado de forma asintomática una infección por COVID-19. Dado que esta complicación es extremadamente infrecuente en pacientes sin factores predisponentes ni infecciones graves, consideramos que la infección por COVID-19 pudo ser un factor desencadenante de la trombosis portal y debemos de tenerlo en cuenta de cara al manejo y tratamiento de futuros casos similares. Read More

View Article and Full-Text PDF

[Manejo de la cesación tabáquica entre residentes de cardiología de Iberoamérica].

Arch Cardiol Mex 2021 May 3. Epub 2021 May 3.

Servicio de Cardiología del Hospital de la Santa Creu i Sant Pau, Instituto de Investigación Biomédica Sant Pau, CIBERCV, Universidad Autónoma de Barcelona, España.

Introducción y objetivos: Si bien los cardiólogos asisten cotidianamente a pacientes que sufren daño por el tabaquismo, no se conoce el grado de formación que reciben sobre esta problemática durante su residencia. Debido a ello nos propusimos evaluar las preferencias y prácticas de los residentes de cardiología para la cesación tabáquica de los pacientes que asisten. Materiales y métodos: Encuesta cerrada, prefijada, voluntaria y anónima entre médicos que realizaban la especialidad de cardiología en cinco países de Latinoamérica y España. Read More

View Article and Full-Text PDF

Metformin as an Alternative Radiosensitizing Agent to 5-Fluorouracil During Neoadjuvant Treatment for Rectal Cancer.

Dis Colon Rectum 2020 07;63(7):918-926

Hospital Sírio-Libanês, São Paulo, Brazil.

Background: Neoadjuvant chemoradiation for locally advanced rectal cancer combining 5-fluorouracil with radiation increases tumor regression compared with radiation alone. However, it occurs at the cost of significant treatment-related toxicity. Patients with rectal cancer using metformin have been associated with improved response to radiotherapy. Read More

View Article and Full-Text PDF

Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.

Dis Colon Rectum 2020 03;63(3):300-309

Centro de Oncologia Molecular-Hospital Sírio Libanês, São Paulo, Brazil.

Background: Patients with rectal cancer may undergo neoadjuvant chemoradiation even in early stages in an attempt to achieve complete clinical response and undergo organ preservation. However, prediction of tumor response is unavailable. In this setting, accurate identification of poor responders could spare patients with early stage disease from potentially unnecessary chemoradiation. Read More

View Article and Full-Text PDF

The risk of eating disorders comorbid with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis.

Int J Eat Disord 2016 Dec 15;49(12):1045-1057. Epub 2016 Nov 15.

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience (IOPPN), King's College, London.

Objective: There has been interest in whether people with Attention-Deficit/Hyperactivity Disorder (ADHD) are at higher risk of developing an Eating Disorder (ED). The aim of this study was estimate the size of this association with a meta-analysis of studies.

Methods: We retrieved studies following PRISMA guidelines from a broad range of databases. Read More

View Article and Full-Text PDF
December 2016

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

J Bras Pneumol 2016 Sep-Oct;42(5):374-385

. WHO Collaborating Centre for TB and Lung Diseases, Fondazione Salvatore Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico - IRCCS - Tradate, Italia.

The role of tuberculosis as a public health care priority and the availability of diagnostic tools to evaluate functional status (spirometry, plethysmography, and DLCO determination), arterial blood gases, capacity to perform exercise, lesions (chest X-ray and CT), and quality of life justify the effort to consider what needs to be done when patients have completed their treatment. To our knowledge, no review has ever evaluated this topic in a comprehensive manner. Our objective was to review the available evidence on this topic and draw conclusions regarding the future role of the "post-tuberculosis treatment" phase, which will potentially affect several million cases every year. Read More

View Article and Full-Text PDF
  • Page 1 of 1